Dr. Anil Gangwe

Consultant, Retina and Uvea Services, MGM Eye Institute, Raipur

1 article

Dr. Anil Babanrao Gangwe completed his MBBS from Seth G. S. Medical College & KEM hospital, Mumbai in 2008. He completed his post graduate degree (MD) in Ophthalmology from Dr. R.P Centre for Ophthalmic Sciences, AIIMS, New Delhi in 2011. He was Senior Resident in Vitreo Retina and ROP services at AIIMS, New Delhi from 2012 to 2015. He has trained general ophthalmologist in ROP screening and management at AIIMS under the National program for control of blindness. He also worked as Consultant- Vitreo Retinal services at Gomabai Netralaya, Neemuch (Madhya Pradesh) from Feb. to Oct. 2015. He joined the Vitreo-Retinal Services at MGM Eye Institute in November 2015. His area of interest are Retinopathy of Prematurity (ROP), ocular trauma, diabetic retinopathy and complex retinal detachment. He has many publication in national and international peer reviewed journals.

  1. Articles 1 Apr 2021 20 min read

    Cytomegalovirus Retinitis Simplified

    Introduction: Cytomegalovirus (CMV) retinitis is an opportunistic viral posterior uveitis that occurs mostly in severely immunocompromised Acquired Immunodeficiency Syndrome (AIDS) patients or, rarely, in those on immunosuppressive therapy after organ transplantation, or who are on systemic corticosteroids.1 More than 75% of AIDS patients with CD4+ counts less than 50 cells/?L have CMV retinitis. It is the most common ocular opportunistic infection in AIDS patients and accounts for 75-85% of all CMV end-organ disease.2 Before the introduction of Highly Active Antiretroviral Treatment (HAART), 30% of patients with Human Immunodeficiency Virus (HIV) developed CMV retinitis during their lifetime, but with the advent of HAART, there is a 75% reduction in the number of new cases of CMV retinitis.3 Rarely, CMV retinitis may occur in non-HIV patients having some degree of immune dysfunction, such as advanced age, diabetes mellitus, corticosteroid, and non-cytotoxic immunosuppressive drug usag